Sandeep Vijan, MD, MS; Rodney A. Hayward, MD
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Vijan S., Hayward R.; Blood Pressure Control in Type 2 Diabetes Mellitus. Ann Intern Med. 2004;140:487-488. doi: 10.7326/0003-4819-140-6-200403160-00021
Download citation file:
Published: Ann Intern Med. 2004;140(6):487-488.
Dr. Krantz points out that ACE inhibitors may be preferred over ARBs for patients with systolic dysfunction or acute MI. We agree, although trials show no clear statistical differences in outcomes between the 2 drugs. However, we would note that our review was of the primary treatment of hypertension in diabetes, not the treatment of comorbid conditions. Many other situations may lead clinicians to alter the initial choice of agent; for example, in patients with angina pectoris, a β-blocker or a calcium-channel blocker may sometimes be preferred, and for those with prostatic hypertrophy, some clinicians may prefer β-blockers. A complete discussion of these conditions was beyond the scope of our review.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only